1. Aspirin for primary prevention of coronary heart disease: safety and absolute benefit related to coronary risk derived from meta-analysis of randomised trials. Issue 3 (1st March 2001) Authors: Sanmuganathan, P S; Ghahramani, P; Jackson, P R; Wallis, E J; Ramsay, L E Journal: Heart Issue: Volume 85:Issue 3(2001) Page Start: 265 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Is the Framingham risk function valid for northern European populations? A comparison of methods for estimating absolute coronary risk in high risk men. Issue 1 (1st January 1999) Authors: Haq, I U; Ramsay, L E; Yeo, W W; Jackson, P R; Wallis, E J Journal: Heart Issue: Volume 81:Issue 1(1999) Page Start: 40 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Population implications of lipid lowering for prevention of coronary heart disease: data from the 1995 Scottish health survey. Issue 3 (1st September 2001) Authors: Haq, I U; Ramsay, L E; Wallis, E J; Isles, C G; Ritchie, L D; Jackson, P R Journal: Heart Issue: Volume 86:Issue 3(2001) Page Start: 289 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗